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Abstract  
Neoplasms of the major and minor salivary glands are morphologically and a clinically diverse group of 
neoplasms which lead the clinician to diagnostic and management challenges. This article aims to report a case 
of mucoepidermoid carcinoma in 83 – year - old woman who presented in the dermatology clinic with a tumour 
mass in the left auricular area. The patient complained of pain and abnormal bleeding of the mass. The lesion 
was examined, and surgical treatment was performed. A tumour was extirpated, and partial resection of both the 
parotid gland and the sternocleidomastoid muscle was done. Lymphatic dissection was performed. Post recovery 
was uneventful with no functional defects and abnormalities. The pathohistological result confirmed the diagnosis 
of mucoepidermoid carcinoma of the parotid gland with massive infiltration of the skin and the subcutaneous 
tissue. Lymph nodules with total metastasis of mucoepidermoid carcinoma and capsular invasion were 
additionally presented. Postoperative radiation therapy was planned. 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Cancers of salivary glands are rare 
malignancies. They represent only 5% of all head and 
neck malignancies [1]. The most common cancer 
among salivary glands' tumours and especially the 
major salivary glands is the mucoepidermoid 
carcinoma of the parotid gland (75%) [2] 
Mucoepidermoid carcinoma is a malignant epithelial 
neoplasm [2]. It is composed of multiple cell types 
which include: epidermoid cells, mucous producing 
cells and intermediate type cells [3]. It presents with a 
prominent cystic growth. Based on its histology 
characteristics, including the cell types, cellular 
differentiation, growth and invasion, cytologic atypia, 
mucoepidermoid carcinoma are graded as low, 
intermediate or high grade [3]. It is more common in 
women than men and usually affects women in their 
fifth decade [4]. 
Also, it is thought that there is a clear 
predilection for white race [5]. Little is known about the 
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aetiology of mucoepidermoid carcinoma, but low-dose 
radiotherapy used for benign diseases as acne and 
obstructive lesions of the lymphoid tissue is probably 
involved in its pathogenesis [5].  
 
 
Case report 
 
We report a case of an 83 – year - old female 
patient with a painful and easily bleeding mass in the 
left auricular area present for one year. The lesion 
was examined preoperatively, and surgical 
management was planned. Patient history included: 
arterial hypertension. On physical examination: a firm 
five/ 5cm mass was palpated in the left auricular 
region. The mass was painful and easily bleeding by 
touch (Fig. 1a). 
 
Figure 1: A - Preoperative aspect before the excision of the tumor; 
B - Intraoperative aspect after the excision of the tumor; C - 
Immediate post-operative result; D - Lobules of cells with abundant 
eosinophilic cytoplasm with one focus of keratinization (on the left) 
representing one area of squamous differentiation; multiple areas of 
ductal and glandular differentiation are also seen; E - Detail of the 
tumour in the the superficial reticular dermis in an area of glandular 
differentiation composed of multiple interconnected lumina lined by 
smaller cells with more scant cytoplasm than those seen in the 
squamous areas 
 
No lymphadenopathy was clinically detected. 
The results of routine blood tests were within normal 
ranges. General anaesthesia was performed. After 
cleaning and disinfection of the surgical field, an 
incision was performed. The cutaneous incision was 
made preauricular near the mandibular border, and 
the tumour was surrounded by healthy tissue. Tumor 
extripation and partial resection of the parotid gland 
has been performed. After hemostasis, a platysma 
myocutaneous flap was made. The mandibular ramus 
of the facial nerve in the area of the posterior facial 
vein was reached and after that following the pathway 
of the mandibular nerve the main trunk of the facial 
nerve was reached (Fig 1b).  
Once the main trunk of the facial nerve was 
exposed, the tumour mass was completely extirpated, 
and both the sternocleoidal muscle and the parotid 
gland were partially resected because of the massive 
tumour infiltration. The neoplasm was extirpated with 
reached negative surgical borders using the bilateral 
pedicle advancement flap. Two pathologically 
changed lymph nodules in the area of the digastricus 
muscle were removed. After partial removal of the 
superficial parotid gland and the tumour, the cut 
surface of the parotid remnant was sutured. 
Hemostasis was achieved. The subcutaneous tissue 
and the skin incision were closed. Closed suction 
drainage was maintained. A thin layer of gauze was 
placed on the wound. The sutures were removed ten 
days after the operation. 
 
 
Discussion 
 
Histologically, MEC is a tumour composed of 
three types of cells: epidermoid, mucous producing 
and intermediate cells [3][4][5]. Based on its 
histological findings it is classified as low, intermediate 
or a high-grade tumour [5]. Low grade and 
intermediate grade appear as well - demarcated with 
pushing margins, but in difference, the intermediate 
one more often presents with a perineural invasion [5]. 
High-grade tumours are being characterised 
by the infiltrative border, diverse of cell abnormalities 
as anaplasia, necrosis and atypical mitoses and 
invasion: perineural and angiolymphatic [5].  
MEC of the parotid gland clinical 
manifestation includes very often asymptomatic 
swelling [5]. There is an average latency period which 
is one year or may vary widely [6]. 
All grade of MEC is treated with surgical 
resection as a definitive treatment [5][6][7][8][9]. A low 
and intermediate grade of tumours often undergoes 
primary surgical excision [5][6][7][8][9][10]. High-grade 
tumours treatment course includes surgical excision 
with wide margins followed by radiotherapy 
[5][6][7][8][9][10]. Neck dissection is necessary if there 
are local metastasis as in our case [5][6][7][8][9][10]. It 
is known that low-grade tumours behave with more 
benign nature and the high grade are highly 
aggressive [6][7]. Intermediate grade presents more 
like a low grade, but they should be treated as high 
grade because they demonstrate predilection to nodal 
metastasis like the high-grade tumours [6][7].  
Prognosis depends on three main factors: 
clinical stage, histological grade and treatment [6]. 
Distant MEC metastases relate to a poor prognosis 
[3]. The survival rate for patients with distant 
metastases is 2.3 - 2.6 years [3]. 
The differential diagnoses spectrum is wide 
and includes necrotising sialometaplasia, mucocele, 
inverted papilloma or cystadenoma, 
cystadenocarcinoma, primary or metastatic 
epidermoid carcinoma, and low-grade polymorphic 
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adenocarcinoma [6].  
It seems that genetic factors of MEC appear 
to do not have a prognostic meaning [3]. Many MEC’s 
have been reported in cytogenetical analyses to have 
the t(11:19), (q21 p13.1) translocation [3]. 
Immunological factors like a high proliferating cell 
nuclear antigen score lead to a less surviving 
percentage of the patients [11].  
Post-operative radiotherapy has been shown 
to have an advantage in the survival of patients with 
tumours larger than 4 cm, and it is not shown as it for 
patients with smaller tumours [5]. Post-operative 
radiotherapy is indicated in patients with tumours 
which are larger than 4 cm [5].  
MEC is a challenge to the clinicians because 
of it its biological behaviour [7]. In our clinical case, we 
present one of its many different behaviours. As firstly, 
it was assumed as a cutaneous tumour involving the 
parotid gland, but it turned out to be the opposite like 
MEC of the parotid gland with massive infiltration in 
the skin of the head.  
However, cutaneous metastases occur in 0.7 
- 10 % of all patients with cancer [12]. ¼ of these 
percentages is for the skin of the head and neck [12]. 
Any malignant neoplasm could have potential to 
metastasize to the head and neck [12]. 
Patients who were treated with MEC should 
be followed up closely for life to prevent late 
recurrence [13]. The morphological manifestation of 
MEC has some similarities with clear cell 
bronchogenic squamous carcinoma [14]. The cell 
proliferation is important criteria for measuring the 
MEC aggressiveness [14]. 
In conclusion, mucoepidermoid carcinoma is 
the most common malignant tumour of the salivary 
glands. It is a challenge to the clinicians and 
especially for the dermatologists. According to the 
literature, it apperas to be a treatable disease.The 
prognosis is in a great relation on not only the tumor 
stage, but also the histological grade of the lesion. 
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